Prova Education

The Value of Biomarkers in MS Patients

The Value of Biomarkers in MS Patients
RestartResume
    Dr. Antonio Uccelli discusses the possible near-term treatment future of patients with multiple sclerosis while at ECTRIMS 2015 in Barcelona, Spain...
    • Overview

      Dr. Antonio Uccelli discusses the possible near-term treatment future of patients with multiple sclerosis while at ECTRIMS 2015 in Barcelona, Spain, highlighting efforts to personalize each patient’s therapy based on MRI status and use of biomarkers as a means to select evidence-based approaches designed to maximize neuroprotection and reduce the realities of disability and brain atrophy.

      This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.

    Facebook Comments

    Register

    We’re glad to see you’re enjoying Prova Education…
    but how about a more personalized experience?

    Register for free